SC 13D Filing

Company

Calidi Biotherapeutics, Inc.

Filed

September 26, 2023

Accession Number

0001493152-23-033652

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →